Mathers Edward T

10% owner at Korro Bio, Inc. · on record since Nov 7, 2023
10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
Director at NeueHealth, Inc. · on record since Oct 6, 2025
10% owner at SpyGlass Pharma, Inc. · on record since Feb 11, 2026
10% owner at NeueHealth, Inc. · on record since Jun 24, 2021
Director at Ra Pharmaceuticals, Inc. · on record since Oct 25, 2016
Director at Trevi Therapeutics, Inc. · on record since Jun 4, 2026
Director at MBX Biosciences, Inc. · on record since Jun 5, 2026
Director at OnKure Therapeutics, Inc. · on record since Jun 8, 2026
Director at SYNLOGIC, INC. · on record since Sep 30, 2015
Director at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 4, 2017
Director at Liquidia Technologies Inc · on record since Jul 27, 2018
Director at Mirum Pharmaceuticals, Inc. · on record since Jul 17, 2019
Director at Akouos, Inc. · on record since Jun 25, 2020
Director at Inozyme Pharma, Inc. · on record since Jul 24, 2020
10% owner at Savara Inc · on record since Mar 16, 2021
10% owner at Monte Rosa Therapeutics, Inc. · on record since Jun 30, 2021
Director at Eloxx Pharmaceuticals, Inc. · on record since Jun 15, 2022
Director at ObsEva SA · on record since Jan 3, 2023
SVP, Corporate Development at · on record since May 31, 2005

Insider trading activity of Mathers Edward T

Transactions on record: 150; since Feb 7, 2006

Open-market buys: 6; $47.3M

Open-market sells: 4; $1.3M

Companies traded: 17; last filing Aug 11, 2026

Figures computed from official regulatory filings — .

Companies where Mathers Edward T has traded

11 tx · Aug 11, 2026
8 tx · $8M · Jun 5, 2026
10 tx · $7.5M · Jun 4, 2026
19 tx · Mar 16, 2026
3 tx · $6M · Mar 12, 2026
9 tx · $15M · Feb 11, 2026
33 tx · $137.8M · Oct 6, 2025
5 tx · Jun 27, 2025
5 tx · Jun 20, 2024
1 tx · $1M · Jul 19, 2023
10 tx · Jun 26, 2023
3 tx · Dec 2, 2022
3 tx · Jun 6, 2022
7 tx · $20M · Jun 30, 2021
6 tx · Apr 3, 2020

Track record of Mathers Edward T

Statistical track record

Free account

Open-market buys: 17

Last buy: Mar 10, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Mathers Edward T

Co-insiders of Mathers Edward T

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
OnKure Therapeutics, Inc.Listing on record	Aug 11, 2026	AwardD (derivative)	22,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OnKure Therapeutics, Inc.Listing on record	Jun 8, 2026	AwardD (derivative)	7,650	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MBX Biosciences, Inc.Listing unverified	Jun 5, 2026	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Trevi Therapeutics, Inc.Listing on record	Jun 4, 2026	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RHYTHM PHARMACEUTICALS, INC.Listing on record	Mar 16, 2026	Other	4,199	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Korro Bio, Inc.Listing on record	Mar 12, 2026	Buy	207,100	11.11 USD	$2.3M	conv 35Cluster	SEC
Korro Bio, Inc.Listing on record	Mar 12, 2026	BuyD (derivative)	242,945	11.11 USD	$2.7M	Cluster	SEC
RHYTHM PHARMACEUTICALS, INC.Listing on record	Mar 4, 2026	Other	4,198	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	737,962	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Buy	937,500	16.00 USD	$15M	conv 45ClusterFirst in 12mo	SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-737,962	—	n/a (No price was disclosed in the filing)		SEC
OnKure Therapeutics, Inc.Listing on record	Jan 2, 2026	Award	3,911	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-125,000	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Sell	-2,455	6.75 USD	$16.6K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	607,536	0.01 USD	$6.1K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Sell	-280	6.75 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	ExerciseD (derivative)	-124,085	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Sell	-900	6.75 USD	$6.1K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
OnKure Therapeutics, Inc.Listing on record	Aug 11, 2026	AwardD (derivative)	22,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OnKure Therapeutics, Inc.Listing on record	Jun 8, 2026	AwardD (derivative)	7,650	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MBX Biosciences, Inc.Listing unverified	Jun 5, 2026	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Trevi Therapeutics, Inc.Listing on record	Jun 4, 2026	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
RHYTHM PHARMACEUTICALS, INC.Listing on record	Mar 16, 2026	Other	4,199	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Korro Bio, Inc.Listing on record	Mar 12, 2026	Buy	207,100	11.11 USD	$2.3M	conv 35Cluster	SEC
Korro Bio, Inc.Listing on record	Mar 12, 2026	BuyD (derivative)	242,945	11.11 USD	$2.7M	Cluster	SEC
RHYTHM PHARMACEUTICALS, INC.Listing on record	Mar 4, 2026	Other	4,198	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	737,962	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Buy	937,500	16.00 USD	$15M	conv 45ClusterFirst in 12mo	SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-737,962	—	n/a (No price was disclosed in the filing)		SEC
OnKure Therapeutics, Inc.Listing on record	Jan 2, 2026	Award	3,911	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-125,000	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Sell	-2,455	6.75 USD	$16.6K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	607,536	0.01 USD	$6.1K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Sell	-280	6.75 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	ExerciseD (derivative)	-124,085	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Sell	-900	6.75 USD	$6.1K		SEC